Identification of genes that confer tumor cell resistance to the Aurora B kinase inhibitor, AZD1152
Authors:
Open Access
- 3 February 2009
- journal article
- research article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 9 (2) , 90-102
Abstract
AZD1152 is a highly selective Aurora B kinase inhibitor currently undergoing Phase I and II clinical evaluation in patients with acute myelogenous leukemia and advanced solid malignancies. We have established two AZD1152-resistant cell lines from SW620 colon and MiaPaCa pancreatic carcinoma lines, which are >100-fold resistant to the active metabolite of AZD1152, AZD1152 HQPA and interestingly, cross-resistant to the pan-Aurora kinase inhibitor, VX-680/MK0457. Using whole-genome microarray analysis and comparative genomic hybridization, we were able to identify MDR1 and BCRP as the causative genes that underlie AZD1152 HQPA-resistance in these models. Furthermore, the upregulation of either of these genes is sufficient to render in vivo tumor growth insensitive to AZD1152. Finally, the upregulation of MDR1 or BCRP is predictive of tumor cell sensitivity to this agent, both in vitro and in vivo. The data provide a genetic basis for resistance to Aurora kinase inhibitors, which could be utilized to predict clinical response to therapy.Keywords
This publication has 33 references indexed in Scilit:
- Molecular Basis of Drug Resistance in Aurora KinasesChemistry & Biology, 2008
- Integrative Genomic Analysis of Small-Cell Lung Carcinoma Reveals Correlates of Sensitivity to Bcl-2 Antagonists and Uncovers Novel Chromosomal GainsMolecular Cancer Research, 2007
- Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinaseProceedings of the National Academy of Sciences, 2007
- Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphomaLeukemia & Lymphoma, 2007
- ABCG2 expression, function, and promoter methylation in human multiple myelomaBlood, 2006
- Aurora-A — A guardian of polesNature Reviews Cancer, 2005
- Aurora kinases in spindle assembly and chromosome segregationExperimental Cell Research, 2004
- The cellular geography of Aurora kinasesNature Reviews Molecular Cell Biology, 2003
- Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistanceOncogene, 2001
- Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin AEuropean Journal of Cancer and Clinical Oncology, 1991